The 2026 Spring Festival Gala Effect: Yiwu Transient Spotlight into Lasting Tourism Growth

A news report from Yiwu Media Convergence Center: On New Year’s Eve, the stunning debut of the Yiwu sub-venue at the 2026 Spring Festival Gala showcased “A Different Yiwu” to the world. Far from concluding with the gala’s end, Yiwu transformed its fleeting on-screen brilliance into a tangible New Year experience, igniting the potential for […]

Aithor Launches AI Detector to Help Educators and Students Identify AI-Generated Writing

Tallinn, Estonia–(Newsfile Corp. – February 21, 2026) – Aithor, an Estonia-based AI technology company, today announced the launch of its AI Detector, a web-based tool designed to help users assess whether written content may include AI-generated text. The release comes as schools, universities, and workplaces continue to update policies around AI use, authorship, and originality

EDR Investors Have Opportunity to Lead Endeavor Group Holdings, Inc. Securities Fraud Lawsuit

Rosen Law Firm, a global investor rights law firm, reminds sellers of Endeavor Group Holdings, Inc. (NYSE: EDR) Class A common stock between January 15, 2025 and March 24, 2025, both dates inclusive (the “Class Period”), of the important March 18, 2026 lead plaintiff deadline. So what: If you sold Endeavor Class A common stock

SMAR Deadline: SMAR Investors with Losses in Excess of $100K Have Opportunity to Lead Smartsheet Inc. Securities Lawsuit

Why: Rosen Law Firm, a global investor rights law firm, reminds all former stockholders of Smartsheet Inc. (NYSE: SMAR) in connection with the January 2025 sale (the “Merger” or “Buyout”) of Smartsheet to affiliates of investment funds managed by affiliates of Blackstone Inc. (collectively “Blackstone”), investment funds managed by Vista Equity Partners Management, LLC (“Vista

Neotext Taps Multi-Awarded Director Alice Waddington to Bring Cult Action Novel Anonymous Jane to the Screen

Photo courtesy of Alice Waddington & Paul Christian PR Art courtesy of Neotext LOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) — Neotext, the digital fiction imprint purpose-built to develop original IP for screen adaptation, has announced that director Alice Waddington is set to co-write and direct a feature film adaptation of Anonymous Jane, the action-spy

Neotext Taps Multi-Awarded Director Alice Waddington to Bring Cult Action Novel Anonymous Jane to the Screen

Neotext Taps Multi-Awarded Director Alice Waddington to Bring Cult Action Novel Anonymous Jane to the Screen GlobeNewswire February 21, 2026 Photo courtesy of Alice Waddington & Paul Christian PR Art courtesy of Neotext LOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) — Neotext, the digital fiction imprint purpose-built to develop original IP for screen adaptation, has

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – QURE

New York, New York–(Newsfile Corp. – February 20, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025 and October 31, 2025, inclusive (the “Class Period”), of the important April 13, 2026 lead plaintiff deadline. SO WHAT: If you

AGILON DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL

New York, New York–(Newsfile Corp. – February 20, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the “Class Period”), of the important March 2, 2026 lead plaintiff deadline in the securities

ROSEN, A TOP RANKED LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RARE

New York, New York–(Newsfile Corp. – February 20, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025, inclusive (the “Class Period”), of the important April 6, 2026 lead plaintiff deadline. SO WHAT: If you

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGNX

New York, New York–(Newsfile Corp. – February 20, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of REGENXBIO, Inc. (NASDAQ: RGNX) between February 9, 2022 and January 27, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed.

Scroll to Top